https://www.pharmanow.live/latest-news/fibrobiologics-secures-australian-patent-cannabidiol-fibroblast-disc-degeneration 2026-08-20T21:49:14+05:30 Pharma Now en 2026-08-20T00:00:00+05:30 FibroBiologics Secures Australian Patent Acceptance for Cannabidiol-Fibroblast Combination in Disc Degeneration https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/acdd03a9-2621-44d2-9eb9-8572a6b84590/7f7eb8ee-f263-410a-bfc9-3c8612626202.png https://www.pharmanow.live/latest-news/pacbio-launches-sprq-nx-vega-benchtop-hifi-sequencing-21-cfr-part-11 2026-08-20T21:48:48+05:30 Pharma Now en 2026-08-20T00:00:00+05:30 PacBio Launches SPRQ-Nx Chemistry on Vega Benchtop System with 21 CFR Part 11 Audit Logging https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://www.pacb.com/wp-content/uploads/banner-1200x300-2.png https://www.pharmanow.live/latest-news/genentech-750m-hillsboro-fill-finish-facility-us-device-manufacturing 2026-08-20T21:55:44+05:30 Pharma Now en 2026-08-20T00:00:00+05:30 Genentech Invests $750M in Hillsboro Fill-Finish Facility to Expand U.S. Device Manufacturing https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/acdd03a9-2621-44d2-9eb9-8572a6b84590/519f449a-a862-4b64-a8fc-753923cf7059.png https://www.pharmanow.live/latest-news/optimal-balance-pharmacy-recalls-compounded-glutathione-elevated-endotoxin 2026-08-20T21:49:36+05:30 Pharma Now en 2026-08-20T00:00:00+05:30 Optimal Balance Pharmacy Recalls Compounded Glutathione Vials After Elevated Endotoxin Levels Detected https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/acdd03a9-2621-44d2-9eb9-8572a6b84590/e046d112-a106-4336-906e-62559fa789ba.png https://www.pharmanow.live/latest-news/ultragenyx-fda-accelerated-approval-genglycos-gsd1a-gene-therapy 2026-08-20T21:51:08+05:30 Pharma Now en 2026-08-20T00:00:00+05:30 Ultragenyx Gains FDA Accelerated Approval for Genglycos in GSD1a, First-Ever Gene Therapy for the Disease https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/acdd03a9-2621-44d2-9eb9-8572a6b84590/b75b93e2-f19d-4b57-b8ba-8c9e442d5dfd.png https://www.pharmanow.live/latest-news/tilray-expands-cannabis-cultivation-capacity-275-metric-tonnes-eu-gmp 2026-08-20T21:47:34+05:30 Pharma Now en 2026-08-20T00:00:00+05:30 Tilray Expands Annual Cannabis Cultivation Capacity Across EU-GMP-Certified Sites https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f876e385-9982-43e0-84b4-2a28d4b89b76/988079af-4ee6-49dd-9887-8ff585a59475.png https://www.pharmanow.live/latest-news/kyverna-therapeutics-gains-rmat-designation-miv-cel-progressive-multiple-sclerosis 2026-08-20T21:47:48+05:30 Pharma Now en 2026-08-20T00:00:00+05:30 Kyverna Therapeutics Gains RMAT Designation for Miv-Cel in Progressive Multiple Sclerosis https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f876e385-9982-43e0-84b4-2a28d4b89b76/87d18783-3e25-4d27-a3ad-c9a373e9d3fd.png https://www.pharmanow.live/latest-news/strides-pharma-bengaluru-facility-eir-us-fda-inspection 2026-08-20T14:01:26+05:30 Pharma Now en 2026-08-20T00:00:00+05:30 Strides Pharma Gains FDA Report for Bengaluru Manufacturing Facility https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/eb6123db-aee3-47e4-88e6-355debe5dcf7/341ebe53-8d59-4a72-a1fa-9a07b2a8e798.png https://www.pharmanow.live/latest-news/glenmark-us-fda-approval-fluticasone-propionate-nasal-spray 2026-08-20T14:05:03+05:30 Pharma Now en 2026-08-20T00:00:00+05:30 Glenmark Gains US FDA Approval For Generic Fluticasone Nasal Spray https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/eb6123db-aee3-47e4-88e6-355debe5dcf7/20900505-7eb2-4a3f-986f-d4edce5bb333.png https://www.pharmanow.live/latest-news/visufarma-exclusive-european-licensing-deal-yuvezzi-presbyopia 2026-08-20T14:04:59+05:30 Pharma Now en 2026-08-20T00:00:00+05:30 VISUfarma Signs European Licensing Deal For YUVEZZI https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/eb6123db-aee3-47e4-88e6-355debe5dcf7/8b562ab4-398b-4124-af40-04fd43cd12f1.png https://www.pharmanow.live/latest-news/telix-pharmaceuticals-h1-2026-results-radiopharmaceutical-revenue-growth 2026-08-20T11:56:48+05:30 Pharma Now en 2026-08-20T00:00:00+05:30 Telix Reports 22% Revenue Growth as Radiopharma Portfolio Scales https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://s.w.org/images/core/emoji/17.0.2/72x72/2122.png https://www.pharmanow.live/latest-news/ascentage-pharma-nine-phase-iii-trials-revenue-growth-h1-2026 2026-08-20T11:56:51+05:30 Pharma Now en 2026-08-20T00:00:00+05:30 Ascentage Pharma Runs Nine Phase III Trials Amid 29% H1 Growth https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a4478e28-2fa6-4afa-ac53-7f97056ff985/8a55d559-1301-4179-a9e6-64910c4a5fee.png https://www.pharmanow.live/latest-news/b-braun-medical-recalls-excel-lactated-ringers-1000ml-particulate-contamination 2026-08-20T11:56:48+05:30 Pharma Now en 2026-08-20T00:00:00+05:30 B. Braun Recalls Lactated Ringers 1000mL Over Contamination https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a4478e28-2fa6-4afa-ac53-7f97056ff985/72904c5d-2c5e-481b-9148-1bd33cfeec3a.png https://www.pharmanow.live/latest-news/ultragenyx-fda-accelerated-approval-genglycos-gsdia 2026-08-20T11:56:47+05:30 Pharma Now en 2026-08-20T00:00:00+05:30 Ultragenyx Wins FDA Approval for Genglycos in GSDIa Patients https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a4478e28-2fa6-4afa-ac53-7f97056ff985/16d69400-8a59-4f19-a853-7f591c86ff08.png https://www.pharmanow.live/latest-news/regeneron-fda-approval-pasatru-garetosmab-fop-home-infusion 2026-08-20T11:57:46+05:30 Pharma Now en 2026-08-20T00:00:00+05:30 Regeneron Wins FDA Approval for Pasatru in FOP, Enables Home Infusion https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/0bf4275c-8dec-42e4-bae7-3901d15ec598/78450f32-1556-4b89-851e-fbc6660a2408.png https://www.pharmanow.live/latest-news/fda-completes-pdufa-vii-cmc-deliverables-accelerated-development 2026-08-20T11:56:45+05:30 Pharma Now en 2026-08-20T00:00:00+05:30 FDA Completes PDUFA VII CMC Deliverables, Sets Submission Benchmarks https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/0bf4275c-8dec-42e4-bae7-3901d15ec598/99b05f22-53e9-4080-8b41-6878e51da55f.png https://www.pharmanow.live/latest-news/mankind-pharma-appoints-sandeep-joshi-avp-international-business 2026-08-19T22:03:06+05:30 Pharma Now en 2026-08-19T00:00:00+05:30 Mankind Pharma Appoints Sandeep Joshi as Associate Vice President of International Business https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/9b5d2877-5f11-45b2-a005-d7bbda2945a2/2cc0f8f1-210f-422c-9be8-3b3e145e7731.png https://www.pharmanow.live/latest-news/gland-pharma-appoints-deepak-sapra-ceo-injectable-expansion 2026-08-19T22:02:22+05:30 Pharma Now en 2026-08-19T00:00:00+05:30 Gland Pharma Appoints Deepak Sapra as CEO Amid Global Injectable Expansion https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/9b5d2877-5f11-45b2-a005-d7bbda2945a2/4b454215-122f-4ce2-bd3d-bce2f3f86e02.png https://www.pharmanow.live/latest-news/teva-fda-priority-review-ecopipam-nda-pediatric-tourette-syndrome 2026-08-19T22:01:12+05:30 Pharma Now en 2026-08-19T00:00:00+05:30 Teva Gains FDA Priority Review for Ecopipam NDA Targeting Pediatric Tourette Syndrome https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/9b5d2877-5f11-45b2-a005-d7bbda2945a2/fb13dda7-5c24-411f-829b-b0ce719f4da4.png https://www.pharmanow.live/latest-news/fda-cber-potency-assessment-guidance-active-immunotherapy-cgt-products 2026-08-19T22:00:40+05:30 Pharma Now en 2026-08-19T00:00:00+05:30 FDA CBER Issues Potency Assessment Guidance for Active Immunotherapy CGT Products https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/9b5d2877-5f11-45b2-a005-d7bbda2945a2/8973b013-decc-4164-bdbd-3e30ea902de8.png https://www.pharmanow.live/latest-news/ideaya-biosciences-signs-clinical-collaboration-genentech-ide892-mtap-deleted-pdac 2026-08-19T21:57:10+05:30 Pharma Now en 2026-08-19T00:00:00+05:30 IDEAYA Biosciences Signs Clinical Collaboration with Genentech for IDE892 in MTAP-Deleted PDAC https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d9571fe4-5037-4654-aacb-9f19486e3400/5b593956-6863-457c-a49f-49c05cd926c7.png https://www.pharmanow.live/latest-news/novartis-esc-2026-cardiovascular-abstracts-inclisiran-abelacimab 2026-08-19T15:17:54+05:30 Pharma Now en 2026-08-19T00:00:00+05:30 Novartis Presents 10 Cardiovascular Abstracts at ESC 2026, Including Phase IV Inclisiran and Abelacimab Data https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/2dbd8e7a-b3e0-43ea-ba0b-0b4e9347f8f8/23b9e905-26c6-4b8e-9387-9eb2b7e9db79.png